H.C. Wainwright analyst Joseph Pantginis downgraded Xoma (XOMA) to Neutral from Buy with a $39 price target citing the pending acquisition by Ligand.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XOMA: